Clinical and pathological roles of Ro/SSA autoantibody system
- PMID: 23304190
- PMCID: PMC3523155
- DOI: 10.1155/2012/606195
Clinical and pathological roles of Ro/SSA autoantibody system
Abstract
Anti-Ro/SSA antibodies are among the most frequently detected autoantibodies against extractable nuclear antigens and have been associated with systemic lupus erythematosus (SLE) and Sjögren's syndrome (SS). Although the presence of these autoantibodies is one of the criteria for the diagnosis and classification of SS, they are also sometimes seen in other systemic autoimmune diseases. In the last few decades, the knowledge of the prevalence of anti-Ro/SSA antibodies in various autoimmune diseases and symptoms has been expanded, and the clinical importance of these antibodies is increasing. Nonetheless, the pathological role of the antibodies is still poorly understood. In this paper, we summarize the milestones of the anti-Ro/SSA autoantibody system and provide new insights into the association between the autoantibodies and the pathogenesis of autoimmune diseases.
References
-
- Chan EKL, Andrade LEC. Antinuclear antibodies in Sjogren’s syndrome. Rheumatic Disease Clinics of North America. 1992;18(3):551–570. - PubMed
-
- von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Seminars in Arthritis and Rheumatism. 1995;24(5):323–358. - PubMed
-
- Yamamoto K. Pathogenesis of Sjogren's syndrome. Autoimmunity Reviews. 2003;2(1):13–18. - PubMed
-
- Kobayashi R, Mii S, Nakano T, Harada H, Eto H. Neonatal lupus erythematosus in Japan: a review of the literature. Autoimmunity Reviews. 2009;8(6):462–466. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
